Horsfieldia macrobotrys Merr has long been used by Dayak people in East Kalimantan of Indonesia, for diabetes therapy. Inspired by ethnopharmacological use and promising -glucosidase and radical scavenging activities, an attempt to identify the active components was carried out. Bioassay-guided isolation yielded two related arylalkanones named 1-(2,4,6-trihydroxyphenyl)-9-phenylnonan-1-one (1) and malabaricone A (2). Arylalkanone 1 showed potent radical scavenging comparable with that of the standard antioxidant, ascorbic acid, and promising inhibition against -glucosidases. Noticeably, arylalkanone 1 was 3-30 times more potent than malabaricone A (2) in all bioassays examined, thus suggesting the critical role in exerting bioactivities of the hydroxy group on the aryl moiety. This hypothesis was also supported by reduction in inhibitory effects of the methyl ether analogues 1a and 2a. Arylalkanone 1 inhibited yeast -glucosidase in a mixed-type manner in which the noncompetitive pathway was dominant over competitive inhibition. This study is the first report of -glucosidase inhibition of arylalkenone-type compounds and the first phytochemicals from H. macrobotrys.
Type-2 diabetes is a metabolic disorder characterized by chronic hyperglycemia associated with complete or partial deficiencies in insulin secretion. The development of the risk of type 2 diabetes may partially mediate the initiation of its complications such as neuropathy, nephropathy and retinopathy. Prolonged postprandial hyperglycemia results in glucose autoxidation, overproduction of free radicals and eventually oxidative stress, which contributes to the aforementioned complications [1, 2] . Nowadays, the main focus of controlling postprandial hyperglycemia is α-glucosidase inhibition, which is exemplified by current antidiabetic drugs including acarbose, voglibose and miglitol [3, 4] . However, none of them can alleviate diabetes complications. Recent evidence indicates that excess plasma glucose drives overproduction of superoxide radicals and other reactive oxygen species that impair the cell through oxidative stress and accounts for the pathogenesis of diabetic complications [5] .
There has been evidence supporting the benefit of using antioxidants along with antidiabetic agents in controlling diabetic development [5] . This approach inspired us to construct bioconjugate molecules possessing such dual functions, thus leading to the discovery of quercityl caffeate as a potent inhibitor against both -glucosidases and free radicals [6] . The idea of applying compounds having dual functions, -glucosidase inhibition and radical scavenging activities, would be more beneficial than current antidiabetic drugs in that they not only suppress blood glucose level but also prevent the onset of diabetic complications triggered by the overproduction of free radicals.
In the present study, we also expand this methodology to search for antidiabetic agents having dual functions from medicinal plants. Inspired H. macrobotrys (syn. Myristica motley), a large tree with a tall straight trunk belonging to the family Myristicaceae, is commonly found in tropical rainforests, including those in East Kalimantan [7] . The genus Horfieldia has been reported as a source of diverse secondary metabolites including arylalkanones [8] [9] [10] , lignans [11] [12] and an indole alkaloid [13] . In our search for -glucosidase inhibitors from edible plants, we found that the extract of H. macrobotrys seed coats revealed a highly inhibitory effect against both DPPH radical and -glucosidase. Coupled with ethnopharmacological use of this plant by native people in Kalimantan for diabetes therapy, an attempt to identify the active components responsible for such bioactivities was performed. To our knowledge, the phytochemical investigation and antidiabetic activity of H. macrobotrys are reported herein for the first time.
The methanol extract, after defatting, was extensively separated by chromatography on Sephadex LH20 using mixtures of MeOH-n-hexane-CH 2 Cl 2 , yielding two related arylalkanones named 1-(2,4,6-trihydroxyphenyl)-9-phenylnonan-1-one (1) and malabaricone A (2) ( Figure 1 ). The identity of the isolated compounds was confirmed by spectroscopic (NMR, IR) and MS analyses, which coincided well with previous reports [8, 14] .
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The isolated arylalkanones 1 and 2 were evaluated for radical scavenging toward DPPH and -glucosidase inhibition. Arylalkanone 1 displayed bioactivities more potent than those of compound 2 in all bioassays examined (Table 1) . Interestingly, radical scavenging of 1 (SC 50 2.6 mM) was comparable with that of ascorbic acid (SC 50 2.5 mM ). The inhibitory effects of 1 against -glucosidases were 7-30 times more pronounced. Notably, the structure of 1 differed from 2 by one additional hydroxyl at C-4. Therefore, it could be generalized that the number of hydroxyl groups on the aryl moiety is critical for exerting radical scavenging and -glucosidase inhibition.
We also envision a bioactivity change if the hydroxyl groups were replaced by alkoxy groups. Arylalkanones 1 and 2 were separately converted to their corresponding methyl ether analogues (1a and 2a, respectively) by reaction with MeI/K 2 CO 3 . The synthesized analogues 1a and 2a were examined for radical scavenging and glucosidase inhibition ( Table 1 ). The replacement of all hydroxyls in 1 by methoxy groups considerably reduced the bioactivities of 1a, by approximately 10-16 times. Similar observations were also noticed for 2a, but were less significant (ca 2-times less potent) in relation to 2. Therefore, the results suggested the critical role of hydroxyls (-OH) in exerting bioactivities, which could not be replaced by the presence of related methyl ether moieties (-OMe) [15] . To our knowledge, there has been no report on -glucosidase inhibition of arylalkanones. We thus attempted to investigate the mechanism underlying this inhibition. A kinetic study of 1, the most potent inhibitor, was conducted against yeast -glucosidase. The Lineweaver-Burk plot of 1 in Figure 2 4 revealed Ki and Ki values of 1.10 and 0.68 mM, respectively, thus suggesting that arylalkanone 1 predominantly formed an ESI complex rather than competitively bound to the enzyme. The proposed inhibitory mechanism is summarized in Scheme 1.
In conclusion, the antidiabetic activity of arylalkanones (1 and 2) , isolated from Horsfieldia macrobotrys, is herein first reported. Arylalkanone 1 could serve as a new potent antidiabetic agent because it revealed both therapeutic effect by inhibiting glucosidase and preventive effect by radical scavenging. In addition, the number of hydroxyl groups on the aryl moiety was crucial for exerting improved bioactivity, which could not be replaced by the presence of methoxy groups in 1a. 
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Experimental General: NMR spectra were recorded on a Bruker 400 AVANCE spectrometer using TMS as an internal reference and the chemical shifts were reported in δ (ppm). TLC was performed using silica gel 60 F 254 aluminium sheets. Spectrophotometric measurements for assay were taken on a Sunrise microplate reader. MS data were obtained using a Bruker MICROTOF model mass spectrometer. 
Extraction and isolation:
The air-dried seed coats of Horsfieldia macrobotrys Merr (300 g), obtained after peeling pericarps, were extracted repeatedly with methanol at room temperature. The methanol extract was concentrated in vacuo to yield a dried extract (20.5 g). A portion of this (12.8 g) was suspended in methanol and partitioned with n-hexane. The methanol soluble fraction was applied to a Sephadex LH-20 column (6:14:80 MeOH-n-hexane-CH 2 Cl 2 ), yielding 14 fractions. The combined fractions 11 to 14 were purified by Sephadex LH-20 (4:16:80 MeOH-n-hexane-CH 2 Cl 2 ) to afford 1-(2,4,6-trihydroxyphenyl)-9-phenylnonan-1-one (1, 216 mg). The combined fractions 3 and 4 were further purified by silica gel (40:60 n-hexane-CH 2 Cl 2 ) to afford 1-(2,6trihydroxyphenyl)-9-phenylnonan-1-one (malabaricone A) (2, 32 mg).
Methylation of 1 and 2:
To a mixture of 1 (20 mg) and K 2 CO 3 (43 mg) dissolved in acetonitrile (1 mL) was added MeI (0.1 mL) dropwise. The reaction mixture was heated at 60 o C for 4 h. The solvent was then removed under reduced pressure to obtain the reaction residue, which was purified by silica gel column chromatography (5:95 EtOAc-n-hexane) to yield 1a (6 mg) [14] . The methyl ether analogue 2a (6 mg) [19] was also prepared using the same protocol starting from 2. 1 
1-(2,4,6-Trimethoxyphenyl)-9-phenylnonan-1-one (1a)

DPPH scavenging assay:
The radical scavenging assay was performed in a 96-well microplate using the protocol described by Clarke and coworkers [16] , with slight modification. All tests were run in triplicate and averaged. Ascorbic acid was used a standard having an inhibition effect against DPPH with an IC 50 value of 2.5 mM.
α-Glucosidase inhibition assay:
The α-glucosidase inhibition assay was performed according to our previous protocols [17] [18] In addition, the inhibition against rat intestinal α-glucosidase (maltase and sucrase) was carried out using a similar protocol. Briefly, 10 μL of the test sample was added to 0.1 M phosphate buffer (pH 6.9, 30 μL), 20 μL of the substrate solution (maltose: 10 mM; sucrose: 100 mM) in 0.1 M phosphate buffer, glucose kit (80 μL) and the crude enzyme solution (20 μL). The reaction mixture was then incubated at 37°C for either 10 min (for maltose) or 40 min (for sucrose). The concentration of glucose released from the reaction mixture was detected by the glucose oxidase method using a glu-kit (Human, Germany). Enzymatic activity was quantified by measuring absorbance at 503 nm.
Kinetic study: In order to evaluate the type of inhibition, enzyme kinetic analysis was performed according to the above reaction. The quantity of yeast α-glucosidase was maintained at 0.4 U/mL, and the concentrations of 1 were varied in the range of 0-2.92 mM. The K i value was determined from secondary plots of slope vs.
[I], and the K' i value was calculated from secondary plots of interception vs.
[I].
